Markets:

Overview

News

Currencies

International

Treasuries

Cencora, Inc. Common Stock (NY:COR)

364.29 +5.04 (+1.40%)

Streaming Delayed Price Updated: 12:38 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance

May 22, 2024

From Cencora

Via Business Wire

Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today ↗

May 16, 2024

Via Benzinga

Unveiling 4 Analyst Insights On Cencora ↗

May 02, 2024

Via Benzinga

COR Stock Earnings: Cencora Beats EPS, Misses Revenue for Q2 2024 ↗

May 01, 2024

COR stock results show that Cencora beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

Cencora Reports Fiscal 2024 Second Quarter Results

May 01, 2024

From Cencora

Via Business Wire

$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today ↗

April 30, 2024

Via Benzinga

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,700 Today ↗

April 16, 2024

Via Benzinga

$1000 Invested In Cencora 5 Years Ago Would Be Worth This Much Today ↗

March 29, 2024

Via Benzinga

3 High-Quality Stocks That Will Never Put You in the Red ↗

April 23, 2024

These quality stocks have real staying power and the ability to generate consistent profits and growth over the long haul.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 09, 2024

Via Benzinga

Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release

April 05, 2024

From Cencora

Via Business Wire

Here's How Much $100 Invested In Cencora 10 Years Ago Would Be Worth Today ↗

March 13, 2024

Via Benzinga

Cencora Announces Leadership Succession Plan

March 12, 2024

From Cencora

Via Business Wire

Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years ↗

February 28, 2024

Via Benzinga

Critical Insights From Cencora Analyst Ratings: What You Need To Know ↗

February 26, 2024

Via Benzinga

Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today ↗

February 09, 2024

Via Benzinga

US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation ↗

February 14, 2024

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.

Via Benzinga

Why Walgreens Boots Alliance Stock Slumped 13.6% in January ↗

February 08, 2024

The pharmacy giant ended an era.

Via The Motley Fool

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

February 07, 2024

From Cencora

Via Business Wire

Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds

February 07, 2024

From Walgreens Boots Alliance

Via Business Wire

Wednesday Is Your Last Chance To Buy Cencora Before The Dividend Payout ↗

February 05, 2024

Via Benzinga

$1000 Invested In This Stock 15 Years Ago Would Be Worth $12,000 Today ↗

February 02, 2024

Via Benzinga

Peering Into Cencora's Recent Short Interest ↗

February 01, 2024

Via Benzinga

Cencora Closes $500 Million Senior Notes Offering

February 07, 2024

From Cencora

Via Business Wire

Cencora Prices $500 Million 5.125% Senior Notes Due 2034

February 05, 2024

From Cencora

Via Business Wire

Drug Wholesale Firm Cencora Starts 2024 With Strong Growth, Lifts Annual Forecast On Commercial COVID-19 Vaccine Distribution ↗

January 31, 2024

Cencora reports Q1 2024 results with adjusted EPS at $3.28 and revenue of $72.3 billion. Explore the company's fiscal year 2024 guidance and growth projections.

Via Benzinga

Cencora Reports Fiscal 2024 First Quarter Results

January 31, 2024

From Cencora

Via Business Wire

How Is The Market Feeling About Cencora? ↗

January 11, 2024

Via Benzinga

Earnings Scheduled For January 31, 2024 ↗

January 31, 2024

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.

Via Benzinga

Chart Of The Day: Cencora - Name Changed To Protect The Innocent? ↗

January 17, 2024

Cencora, Inc. sources and distributes pharmaceutical products.

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Cencora, Inc. Common Stock (NY:COR)

All News about Cencora, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today